Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Pharnext

    MCap

    1m

    Last close

    EUR0.10

    ▲ 0.03 (42.86%)

    MGI – Media and Games Invest

    MCap

    EUR235m

    Last close

    EUR1.50

    ▲ 0.35 (30.21%)

    CI Games

    MCap

    PLN271m

    Last close

    PLN1.84

    ▲ 0.36 (24.32%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Belluscura: Edison Open House Healthcare 2022

Belluscura: Edison Open House Healthcare 2022

Belluscura is a publicly traded UK company listed on the AIM submarket of the London Stock Exchange (AIM: BELL). Belluscura focuses on developing and commercialising innovative oxygen enrichment technologies that span broad industries and therapies.

• What does Belluscura’s oxygen do and what are its advantages for patients?
• What are the opportunities for Belluscura in a market dominated by a handful of well-established players?
• Please tell more about the plans for your two new products, X-PLO₂R CX and X-PLO₂R DX.
• Tell us about the large market for these products.
• What is your intellectual property strategy and are partnerships part of the plan to add more to your patent portfolio?
• Is noise a consideration?
• When entering different markets such as wound care, how will you approach the requirement for extra development?
• Which company events should investors look out for in the coming months?

< Previous
Next >

You may also be interested in these:

Investment Companies

Vantage: Investing for impact with Downing’s diversified approach to the energy transition

Investment Companies

Molten Ventures – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free